0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
ARTICLE |

Metastatic Chordoma:  Use of Mechlorethamine (Nitrogen Mustard) in Chordoma Therapy

AUSTIN J. McSWEENEY, M.D.; P. RICHARD SHOLL, M.D.
AMA Arch Surg. 1959;79(1):152-155. doi:10.1001/archsurg.1959.04320070156027.
Text Size: A A A
Published online

The sacrococcygeal chordoma is a rare tumor which is generally believed to arise from remnants of embryonic notochordal tissues. These may persist as the nucleus pulposus or in scattered nodular rests in some 2% of humans.1 A recent review of the literature revealed a total of 505 cases of chordoma.2 Chordomas show a predilection for the sacrum and coccyx, and about half are located in these areas. Although chordomas are malignant tumors in every sense and are locally invasive, proved metastases are very uncommon. Apparently, metastases from mucus-producing carcinomas of the rectum have in some cases been confused with metastatic chordoma. We are aware of only one case of presumable distant bony metastasis of a chordoma, but this was not proved by histologic examination.3

The primary therapeutic approach to sacrococcygeal chordomas is surgical. Block removal of the coccyx, most of the sacrum, and the tumor is recommended

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Correspondence

CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();